Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAMPT | P43490 | 14/20 | 0.46 |
| ▸ | VNN1 | O95497 | 1/20 | 0.41 |
| ▸ | PRMT3 | O60678 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.38 |
| ▸ | EPAS1 | Q99814 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31037302 | 0.84 | NAMPT (0.51) | NAMPTPRMT3LMNA | |
| SCHEMBL31744293 | 0.83 | NAMPT (0.46) | NAMPTPRMT3HIF1AEPAS1 | |
| SCHEMBL31037336 | 0.82 | NAMPT (0.42) | NAMPTPRMT3LMNA | |
| SCHEMBL31037468 | 0.81 | LMNA (0.44) | NAMPTPRMT3LMNA | |
| SCHEMBL31037327 | 0.80 | PRMT3 (0.55) | NAMPTPRMT3LMNA | |
| SCHEMBL31037296 | 0.79 | ALK (0.41) | NAMPTLMNAKMT2A | |
| SCHEMBL31037269 | 0.78 | ROCK2 (0.46) | NAMPTPRMT3 | |
| SCHEMBL31037483 | 0.77 | NAMPT (0.47) | NAMPTPRMT3LMNAHIF1AEPAS1 | |
| SCHEMBL31037286 | 0.77 | LMNA (0.48) | NAMPTPRMT3LMNAKMT2A | |
| SCHEMBL31037293 | 0.77 | LMNA (0.48) | NAMPTPRMT3LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4663628-A1 | NEW COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | Samjin Pharmaceutical Co., Ltd. (KR) | 2025-12-17 | — | — | EP | disclosed |
| WO-2024166024-A1 | NEW COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | 삼진제약주식회사 | 2024-08-15 | — | — | WO | disclosed |